Vir Biotechnology, Inc.
VIR
$9.26
-$0.22-2.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 60.68M | 240.00K | 1.21M | 3.03M | 10.03M |
| Total Other Revenue | 3.39M | -- | -- | -- | 2.34M |
| Total Revenue | 64.07M | 240.00K | 1.21M | 3.03M | 12.37M |
| Cost of Revenue | 88.46M | 151.45M | 97.52M | 117.62M | 102.94M |
| Gross Profit | -24.39M | -151.21M | -96.31M | -114.58M | -90.56M |
| SG&A Expenses | 23.62M | 22.23M | 22.28M | 23.94M | 26.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 112.07M | 173.68M | 119.80M | 141.56M | 129.64M |
| Operating Income | -48.00M | -173.44M | -118.59M | -138.53M | -117.27M |
| Income Before Tax | -43.06M | -162.97M | -110.79M | -120.95M | -104.68M |
| Income Tax Expenses | -137.00K | 168.00K | 170.00K | 16.00K | -86.00K |
| Earnings from Continuing Operations | -42.92M | -163.14M | -110.96M | -120.97M | -104.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.92M | -163.14M | -110.96M | -120.97M | -104.59M |
| EBIT | -48.00M | -173.44M | -118.59M | -138.53M | -117.27M |
| EBITDA | -45.10M | -170.45M | -115.67M | -135.66M | -114.38M |
| EPS Basic | -0.31 | -1.17 | -0.80 | -0.88 | -0.76 |
| Normalized Basic EPS | -0.18 | -0.74 | -0.49 | -0.57 | -0.47 |
| EPS Diluted | -0.31 | -1.17 | -0.80 | -0.88 | -0.76 |
| Normalized Diluted EPS | -0.18 | -0.74 | -0.49 | -0.57 | -0.47 |
| Average Basic Shares Outstanding | 139.22M | 138.93M | 138.45M | 137.47M | 136.81M |
| Average Diluted Shares Outstanding | 139.22M | 138.93M | 138.45M | 137.47M | 136.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |